Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: Gastroenterology. 2020 Jun 24;159(1):289–305.e16. doi: 10.1053/j.gastro.2020.03.013

Figure 1. High expression of ABL1 in human HCCs is positively correlated with shorter survival times of patients.

Figure 1.

(A) Relative expression of ABL1 mRNA in normal liver and HCC specimens from the TCGA database. (B) ABL1 mRNA expression is correlated with shorter survival times of HCC patients. (C) Representative photos of ABL1 and p-ABL1 IHC staining in adjacent normal liver and HCC specimens from tissue microarrays. (D&E) Quantification of ABL1 and p-ABL1 IHC staining from tissue microarrays (66 cases of HCC and 50 normal tissue specimens).